Presentation is loading. Please wait.

Presentation is loading. Please wait.

Can Adenosine 5′-Triphosphate Be Used to Select Treatment in Severe Vasovagal Syndrome? by Daniel Flammang, Timothy Church, Marc Waynberger, Annick Chassing,

Published byGiles Simon Lester Modified over 8 years ago

Similar presentations

Presentation on theme: "Can Adenosine 5′-Triphosphate Be Used to Select Treatment in Severe Vasovagal Syndrome? by Daniel Flammang, Timothy Church, Marc Waynberger, Annick Chassing,"— Presentation transcript:

1 Can Adenosine 5′-Triphosphate Be Used to Select Treatment in Severe Vasovagal Syndrome? by Daniel Flammang, Timothy Church, Marc Waynberger, Annick Chassing, and Mark Antiel Circulation Volume 96(4):1201-1208 August 19, 1997 Copyright © American Heart Association, Inc. All rights reserved.

2 Tracings show typical normal responses to ATP test. Daniel Flammang et al. Circulation. 1997;96:1201-1208 Copyright © American Heart Association, Inc. All rights reserved.

3 Typical abnormal response to ATP test (continuous tracing) shows a complete AV block of 15 seconds with two ventricular escape beats (phase [ph.] III) and a second-degree AV block of variable severity lasting 10.5 seconds (phase IV). Daniel Flammang et al. Circulation. 1997;96:1201-1208 Copyright © American Heart Association, Inc. All rights reserved.

4 In phase III, 6% of normal subjects and 41% of symptomatic patients had cardiac pauses >10 seconds (P<.0001). Daniel Flammang et al. Circulation. 1997;96:1201-1208 Copyright © American Heart Association, Inc. All rights reserved.

5 Actuarial curve of recurrence-free survival. Daniel Flammang et al. Circulation. 1997;96:1201-1208 Copyright © American Heart Association, Inc. All rights reserved.

Download ppt "Can Adenosine 5′-Triphosphate Be Used to Select Treatment in Severe Vasovagal Syndrome? by Daniel Flammang, Timothy Church, Marc Waynberger, Annick Chassing,"

Similar presentations

Adenosine testing in syncope Dr Steve W Parry Falls and Syncope Service Royal Victoria Infirmary and Institute for Ageing and Health, Newcastle University.

Adenosine testing in syncope Dr Steve W Parry Falls and Syncope Service Royal Victoria Infirmary and Institute for Ageing and Health, Newcastle University.
Tachyarrhythmia Approach to management: 1. Determine if there is a pulse – If no pulse, initiate management for pulseless arrest 2. Determine if patient.

Tachyarrhythmia Approach to management: 1. Determine if there is a pulse – If no pulse, initiate management for pulseless arrest 2. Determine if patient.
Date of download: 6/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Giant T–U Waves Precede Torsades de Pointes in Long.

Date of download: 6/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Giant T–U Waves Precede Torsades de Pointes in Long.
Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.

Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pulmonary Arterial Hypertension J Am Coll Cardiol.

Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pulmonary Arterial Hypertension J Am Coll Cardiol.
Cumulative Radiation Exposure and Cancer Risk Estimation in Children With Heart DiseaseCLINICAL PERSPECTIVE by Jason N. Johnson, Christoph P. Hornik, Jennifer.

Cumulative Radiation Exposure and Cancer Risk Estimation in Children With Heart DiseaseCLINICAL PERSPECTIVE by Jason N. Johnson, Christoph P. Hornik, Jennifer.
Improved Survival After Out-of-Hospital Cardiac Arrest and Use of Automated External DefibrillatorsCLINICAL PERSPECTIVE by Marieke T. Blom, Stefanie G.

Improved Survival After Out-of-Hospital Cardiac Arrest and Use of Automated External DefibrillatorsCLINICAL PERSPECTIVE by Marieke T. Blom, Stefanie G.
Elastin Stabilizes an Infarct and Preserves Ventricular Function by Tomohiro Mizuno, Terrence M. Yau, Richard D. Weisel, Chris G. Kiani, and Ren- Ke Li.

Elastin Stabilizes an Infarct and Preserves Ventricular Function by Tomohiro Mizuno, Terrence M. Yau, Richard D. Weisel, Chris G. Kiani, and Ren- Ke Li.
Early Outcomes of Tricuspid Valve Replacement in Young Children by Heather L. Bartlett, Dianne L. Atkins, Trudy L. Burns, Kelly J. Engelkes, Sarah J. Powell,

Early Outcomes of Tricuspid Valve Replacement in Young Children by Heather L. Bartlett, Dianne L. Atkins, Trudy L. Burns, Kelly J. Engelkes, Sarah J. Powell,
Omega-3 Fatty Acid Blood Levels by H. Robert Superko, Scott M. Superko, Khurram Nasir, Arthur Agatston, and Brenda C. Garrett Circulation Volume 128(19):2154-2161.

Omega-3 Fatty Acid Blood Levels by H. Robert Superko, Scott M. Superko, Khurram Nasir, Arthur Agatston, and Brenda C. Garrett Circulation Volume 128(19):
Guide to the Assessment of Physical Activity: Clinical and Research Applications by Scott J. Strath, Leonard A. Kaminsky, Barbara E. Ainsworth, Ulf Ekelund,

Guide to the Assessment of Physical Activity: Clinical and Research Applications by Scott J. Strath, Leonard A. Kaminsky, Barbara E. Ainsworth, Ulf Ekelund,
Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction by Mikhail Kosiborod, Saif S. Rathore, Silvio E. Inzucchi,

Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction by Mikhail Kosiborod, Saif S. Rathore, Silvio E. Inzucchi,
Luigi Luciani and the Earliest Graphic Demonstration of Wenckebach Periodicity by Charles B. Upshaw, and Mark E. Silverman Circulation Volume 101(22):2662-2668.

Luigi Luciani and the Earliest Graphic Demonstration of Wenckebach Periodicity by Charles B. Upshaw, and Mark E. Silverman Circulation Volume 101(22):
A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous.

A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous.
Enhanced Effect of Combining Human Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and to Restore Cardiac Function After.

Enhanced Effect of Combining Human Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and to Restore Cardiac Function After.
From: High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study Ann Intern Med. 2004;140(2):85-93.

From: High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study Ann Intern Med. 2004;140(2):85-93.
Algorithm for the management of aortic valve stenosis

Algorithm for the management of aortic valve stenosis
Circ Arrhythm Electrophysiol

Circ Arrhythm Electrophysiol
Copyright © 2015 by the American Osteopathic Association.

Copyright © 2015 by the American Osteopathic Association.
Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States by Brahmajee K. Nallamothu, Eric R. Bates, Yongfei.

Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States by Brahmajee K. Nallamothu, Eric R. Bates, Yongfei.

Similar presentations

Ads by Google